azd2563 has been researched along with moxifloxacin in 2 studies
Studies (azd2563) | Trials (azd2563) | Recent Studies (post-2010) (azd2563) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
---|---|---|---|---|---|
29 | 0 | 9 | 3,157 | 552 | 1,690 |
Protein | Taxonomy | azd2563 (IC50) | moxifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N | 1 |
Jeong, BH; Koh, WJ; Kwon, YS | 1 |
2 review(s) available for azd2563 and moxifloxacin
Article | Year |
---|---|
Tuberculosis: the drug development pipeline at a glance.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Humans; Tuberculosis | 2012 |
Tuberculosis: clinical trials and new drug regimens.
Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |